Meagan Hansen
Family · Springfield, MONPI 1801535836
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,906, more than ten times the $34 reported in 2023.
Across 156 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$517
- Otsuka America Pharmaceutical, Inc.$388
- Alkermes, Inc.$381
- E.r. Squibb & Sons, L.L.C.$234
- Neurocrine Biosciences, Inc.$204
- Viiv Healthcare Company$145
- plus $844 from 13 others
What the payments were for
- Food & beverage$2,709100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $517 |
| Otsuka America Pharmaceutical, Inc. | 27 | $388 |
| Alkermes, Inc. | 21 | $381 |
| E.r. Squibb & Sons, L.L.C. | 12 | $234 |
| Neurocrine Biosciences, Inc. | 9 | $204 |
| Viiv Healthcare Company | 7 | $145 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $136 |
| Indivior Inc. | 7 | $136 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Lundbeck LLC | 5 | $92 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| Johnson & Johnson | 4 | $78 |
| Braeburn Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Globus Medical | 1 | $33 |
| Dexcom, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Pfizer | 1 | $18 |
How this compares
$2,712 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 67 | $10,536 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,643 |
| Buprenorphine Hcl | 36 | $2,604 |
| Ventolin HfaAlbuterol Sulfate | 11 | $577 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $508 |
| Omeprazole | 23 | $302 |
| Gabapentin | 20 | $270 |
| Buspirone Hcl | 15 | $237 |
| Pantoprazole Sodium | 18 | $197 |
| Clonazepam | 11 | $122 |
| Lisinopril | 18 | $65 |
| Metoprolol Tartrate | 15 | $46 |
| Trazodone Hcl | 15 | $43 |
| Metformin Hcl | 23 | $29 |
| Topiramate | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other family in Springfield
- Laura HedigerSpringfield$71K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.